Clinical Trial Update: A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

View source ↗

Summary

This clinical trial update discusses potential risks of suicidality, psychosis, or substance abuse associated with ADHD medications including methylphenidate, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Amphetamine/Dextroamphetamine (mixed amphetamine salts)
• Atomoxetine (Atomoxetine)
• Lisdexamfetamine (lisdexamfetamine dimesylate)
• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Attention Deficit Disorder With Hyperactivity | Status: COMPLETED